PubMed

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

Diabetes Care. 2002 Nov;25(11):2053-7.PMID: 12401756 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.

Hirao K, Maeda H, Urata S, Takisawa Y, Hirao S, Sasako T, Sasaki T.

Clin Ther. 2007 May;29(5):927-34.PMID: 17697911 [PubMed - indexed for MEDLINE]Related articles

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

Clin Ther. 2009 May;31(5):980-7.PMID: 19539098 [PubMed - indexed for MEDLINE]Related articles

Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.

Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.

Acta Diabetol. 2000 Mar;37(1):41-6.PMID: 10928235 [PubMed - indexed for MEDLINE]Related articles

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

Lindholm A, McEwen J, Riis AP.

Diabetes Care. 1999 May;22(5):801-5.PMID: 10332685 [PubMed - indexed for MEDLINE]Related articlesFree article

Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.

Bartolo PD, Pellicano F, Scaramuzza A, Sardu C, Casetti T, Bosi E, Miselli V, Brandolini S, Fabbri T, Meandri P, Cannatà F.

Diabetes Technol Ther. 2008 Dec;10(6):495-8.PMID: 19049379 [PubMed - indexed for MEDLINE]Related articles

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

Diabetes Care. 2002 May;25(5):883-8.PMID: 11978685 [PubMed - indexed for MEDLINE]Related articlesFree article

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.

McSorley PT, Bell PM, Jacobsen LV, Kristensen A, Lindholm A.

Clin Ther. 2002 Apr;24(4):530-9.PMID: 12017398 [PubMed - indexed for MEDLINE]Related articles

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.

Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AA, Berger M.

Diabet Med. 1996 Jul;13(7):625-9.PMID: 8840095 [PubMed - indexed for MEDLINE]Related articles

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

Home PD, Lindholm A, Hylleberg B, Round P.

Diabetes Care. 1998 Nov;21(11):1904-9.PMID: 9802741 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Lindholm A, Jacobsen LV.

Clin Pharmacokinet. 2001;40(9):641-59. Review.PMID: 11605714 [PubMed - indexed for MEDLINE]Related articles

Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs.

Lindström T, Hedman CA, Arnqvist HJ.

Diabetes Care. 2002 Jun;25(6):1049-54.PMID: 12032113 [PubMed - indexed for MEDLINE]Related articlesFree article

The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart: a randomized, glucose clamp, crossover study.

Heise T, Eckers U, Kanc K, Nielsen JN, Nosek L.

Diabetes Technol Ther. 2008 Dec;10(6):479-85.PMID: 19049377 [PubMed - indexed for MEDLINE]Related articles

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA.

Diabetes Care. 1998 Apr;21(4):570-3.PMID: 9571344 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT.

Diabetes Care. 2001 May;24(5):886-90.PMID: 11347749 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.

Diabetes Care. 1999 Sep;22(9):1501-6.PMID: 10480516 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

Ahmed AB, Home PD.

Diabetes Care. 1998 Jan;21(1):32-7.PMID: 9538967 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.

Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G.

Diabetes Care. 2003 Jul;26(7):2027-31.PMID: 12832307 [PubMed - indexed for MEDLINE]Related articlesFree article